What is the appropriate esomeprazole dose for a 5‑kg child with gastro‑oesophageal reflux disease?

Esomeprazole Dosing for a 5 kg Infant with GERD

For a 5 kg infant with GERD, esomeprazole should be dosed at 3.5 to 5 mg once daily (0.7–1.0 mg/kg/day), administered as capsule contents sprinkled onto soft foods or mixed in juice. 1

Weight-Based Dosing Strategy

• The American Academy of Pediatrics recommends esomeprazole at 0.7–3.3 mg/kg/day for children aged 1–17 years 1
• For a 5 kg infant, this translates to:
  • Minimum dose: 3.5 mg daily (0.7 mg/kg)
  • Maximum dose: 16.5 mg daily (3.3 mg/kg)
  • Practical starting dose: 5 mg daily (1.0 mg/kg) 1

Age-Specific Considerations

• Esomeprazole is FDA-approved for children ≥1 year of age 1
• If this infant is under 12 months old, esomeprazole use is off-label and should be approached with caution 1
• For infants under 1 year, PPIs have NOT demonstrated superiority over placebo for reducing irritability in clinical trials 1

Critical Clinical Decision Points

Before prescribing any PPI to an infant:

• Rule out "red flag" symptoms (projectile vomiting, bile-stained vomiting, hematemesis, blood in stool, abdominal distension, systemic features) that suggest more serious conditions requiring different management 2
• Confirm true GERD rather than physiologic reflux, which is common in infancy and typically resolves by age 1 year without medication 2
• Consider simple interventions first: feed modifications, thickening agents, and parental reassurance before acid suppression 2

Dosing Evidence from Clinical Trials

Research in infants demonstrates:

• Esomeprazole 0.25 mg/kg and 1.0 mg/kg both provided dose-related acid suppression in infants 1–24 months old 3
• The 1.0 mg/kg dose achieved 69.3% of time with intragastric pH >4 compared to 47.9% with 0.25 mg/kg 3
• Esomeprazole 0.2–1.0 mg/kg effectively healed erosive esophagitis in children aged 1–11 years 4

Administration Method

• Sprinkle capsule contents onto soft foods or administer in juice 1
• Can be given through nasogastric tube if needed 1
• Administer once daily, typically before the first meal

Safety Concerns Specific to Infants

Critical warnings for PPI use in young infants:

• Infants on PPIs may be at increased risk of lower respiratory tract infections, gastroenteritis, candidemia, and necrotizing enterocolitis in preterm infants 1
• Placebo-controlled trials in infants have not demonstrated PPI superiority over placebo for symptom reduction 1
• Side effects occur in up to 14% of children and include headaches, diarrhea, constipation, and nausea 1

Alternative Approach if Under 1 Year Old

If this 5 kg infant is under 12 months and symptoms persist despite conservative measures:

• Consider H2-receptor antagonists as an alternative (ranitidine 5–10 mg/kg/day divided in 2–3 doses, though availability varies) 1
• Reassess the diagnosis to ensure GERD is truly present and not physiologic reflux 2
• Reevaluate in 1–2 weeks as most infantile reflux improves spontaneously 2

Duration and Monitoring

• Initial treatment trial: 8 weeks 4, 5
• Monitor for symptom improvement every 2 weeks 5
• If effective and continued treatment needed, maintenance dosing can be reduced to 0.5 mg/kg/day (2.5 mg daily for this 5 kg infant) after achieving remission 6